WallStSmart

Centene Corp (CNC)vsHumana Inc (HUM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Centene Corp generates 36% more annual revenue ($176.15B vs $129.66B). HUM leads profitability with a 92.0% profit margin vs -3.8%. CNC appears more attractively valued with a PEG of 0.77. CNC earns a higher WallStSmart Score of 65/100 (B-).

CNC

Strong Buy

65

out of 100

Grade: B-

Growth: 8.0Profit: 4.0Value: 6.7Quality: 5.8
Piotroski: 4/9Altman Z: 2.71

HUM

Buy

58

out of 100

Grade: C

Growth: 5.3Profit: 5.5Value: 7.3Quality: 8.5
Piotroski: 4/9Altman Z: 4.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CNC.

HUMSignificantly Overvalued (-156.9%)

Margin of Safety

-156.9%

Fair Value

$68.27

Current Price

$169.90

$101.63 premium

UndervaluedFair: $68.27Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CNC4 strengths · Avg: 8.5/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.778/10

Growing faster than its price suggests

Revenue GrowthGrowth
23.2%8/10

Revenue surging 23.2% year-over-year

EPS GrowthGrowth
21.8%8/10

Earnings expanding 21.8% YoY

HUM5 strengths · Avg: 9.2/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Profit MarginProfitability
92.0%10/10

Keeps 92 of every $100 in revenue as profit

Altman Z-ScoreHealth
4.3710/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.978/10

Growing faster than its price suggests

P/E RatioValuation
16.9x8/10

Attractively priced relative to earnings

Areas to Watch

CNC3 concerns · Avg: 1.3/10
Return on EquityProfitability
-28.7%2/10

ROE of -28.7% — below average capital efficiency

Profit MarginProfitability
-3.8%1/10

Currently unprofitable

Operating MarginProfitability
-1.9%1/10

Operating margin of -1.9%

HUM4 concerns · Avg: 2.0/10
Return on EquityProfitability
7.0%3/10

ROE of 7.0% — below average capital efficiency

EPS GrowthGrowth
-59.3%2/10

Earnings declined 59.3%

Free Cash FlowQuality
$-1.85B2/10

Negative free cash flow — burning cash

Operating MarginProfitability
-1.8%1/10

Operating margin of -1.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : CNC

The strongest argument for CNC centers on Price/Book, PEG Ratio, Revenue Growth. Revenue growth of 23.2% demonstrates continued momentum. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bull Case : HUM

The strongest argument for HUM centers on Price/Book, Profit Margin, Altman Z-Score. Profitability is solid with margins at 92.0% and operating margin at -1.8%. Revenue growth of 11.3% demonstrates continued momentum.

Bear Case : CNC

The primary concerns for CNC are Return on Equity, Profit Margin, Operating Margin.

Bear Case : HUM

The primary concerns for HUM are Return on Equity, EPS Growth, Free Cash Flow.

Key Dynamics to Monitor

CNC profiles as a growth stock while HUM is a mature play — different risk/reward profiles.

CNC carries more volatility with a beta of 0.46 — expect wider price swings.

CNC is growing revenue faster at 23.2% — sustainability is the question.

CNC generates stronger free cash flow (224M), providing more financial flexibility.

Bottom Line

CNC scores higher overall (65/100 vs 58/100) and 23.2% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Centene Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.

Humana Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.

Visit Website →

Want to dig deeper into these stocks?